Santen Pharmaceutical Co., Ltd. (TYO:4536)

Santen Pharmaceutical Revenue

Santen Pharmaceutical had revenue of 68.96B JPY in the quarter ending June 30, 2026, with 0.32% growth. This brings the company's total for the last twelve months to 291.84B, down -0.72% year-over-year. In the fiscal year ending March 31, 2026, Santen Pharmaceutical had annual revenue of 291.62B, down -2.79%. That makes Santen Pharmaceutical the 5,223rd largest company in the world by revenue and 534th in Japan.

• Revenue (ttm): 291.84B
• Revenue Growth: -0.72%
• P/S Ratio: 1.95
• Revenue / Employee: 73.55M
• Employees: 3,968
• Market Cap: 568.67B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Japan 146.81B 50.3%
• Europe, Middle East and Africa (EMEA) 80.10B 27.5%
• Asia (Exclude China) 33.25B 11.4%
• China 30.01B 10.3%
• Others 1.45B 0.5%

Fiscal year ended Mar 31, 2026 See the full Santen Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	291.62B	-8.38B	-2.79%
Mar 31, 2025	300.00B	-1.96B	-0.65%
Mar 31, 2024	301.97B	22.93B	8.22%
Mar 31, 2023	279.04B	12.78B	4.80%
Mar 31, 2022	266.26B	16.65B	6.67%

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error